人工表面活性剂对特发性呼吸窘迫综合征肺功能和血气的影响。
Effects of artificial surfactant on lung function and blood gases in idiopathic respiratory distress syndrome.
作者信息
Milner A D, Vyas H, Hopkin I E
出版信息
Arch Dis Child. 1983 Jun;58(6):458-60. doi: 10.1136/adc.58.6.458.
Abstract
We have investigated the effect of giving two 25 mg doses of dry surfactant powder to the airways of 10 preterm babies with severe idiopathic respiratory distress syndrome requiring intermittent positive pressure ventilation. No useful change in static total compliance or blood gases was seen. We conclude that dry surfactant powder does not have a role in the management of severe idiopathic respiratory distress syndrome.
摘要
我们研究了给10名患有严重特发性呼吸窘迫综合征且需要间歇性正压通气的早产婴儿气道给予两剂25毫克干表面活性剂粉末的效果。未观察到静态总顺应性或血气有任何有益变化。我们得出结论，干表面活性剂粉末在严重特发性呼吸窘迫综合征的治疗中没有作用。
相似文献
1
Effects of artificial surfactant on lung function and blood gases in idiopathic respiratory distress syndrome.人工表面活性剂对特发性呼吸窘迫综合征肺功能和血气的影响。
Arch Dis Child. 1983 Jun;58(6):458-60. doi: 10.1136/adc.58.6.458.
2
Cerebral hemodynamics after exogenous surfactant administration for respiratory distress syndrome in piglet model.
J Perinat Med. 2000;28(5):363-71. doi: 10.1515/JPM.2000.046.
3
The effect of reconstituted bovine surfactant on pulmonary mechanics in infants with respiratory distress syndrome.重组牛肺表面活性物质对呼吸窘迫综合征婴儿肺力学的影响。
Acta Paediatr Jpn. 1989 Dec;31(6):734-41. doi: 10.1111/j.1442-200x.1989.tb01388.x.
4
Effect of exogenous surfactant on total respiratory system compliance.外源性表面活性剂对总呼吸系统顺应性的影响。
Arch Dis Child. 1984 Apr;59(4):369-71. doi: 10.1136/adc.59.4.369.
5
Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome.给患有呼吸窘迫综合征的婴儿使用表面活性剂后肺力学的变化。
N Engl J Med. 1988 Aug 25;319(8):476-9. doi: 10.1056/NEJM198808253190804.
6
Artificial surfactant treatment in lambs with severe respiratory distress syndrome: a controlled study.
J Pediatr. 1983 Mar;102(3):450-3. doi: 10.1016/s0022-3476(83)80675-1.
7
Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome.严重呼吸窘迫综合征早产儿表面活性剂治疗后呼吸系统的功能残气量和顺应性
Eur J Pediatr. 2002 Sep;161(9):485-90. doi: 10.1007/s00431-002-0989-6. Epub 2002 Jul 12.
8
Surfactant replacement in neonatal and adult respiratory distress syndrome.新生儿及成人呼吸窘迫综合征中的表面活性剂替代疗法
Eur J Anaesthesiol. 1984 Dec;1(4):335-43.
9
[Etiology, pathogenesis and possible treatment of 'respiratory distress syndrome'].
Tidsskr Nor Laegeforen. 1974 Apr 20;94(11):677-84.
10
Natural surfactant instilled in premature lambs increases lung volume and improves ventilation homogeneity within five minutes.给早产羔羊注入天然表面活性剂可在五分钟内增加肺容量并改善通气均匀性。
Pediatr Res. 1992 Nov;32(5):595-9. doi: 10.1203/00006450-199211000-00023.
引用本文的文献
1
Pulmonary surfactant and COVID-19: A new synthesis.肺表面活性物质与新型冠状病毒肺炎：一种新的综合阐述
QRB Discov. 2022 Apr 22;3:e6. doi: 10.1017/qrd.2022.1. eCollection 2022.
2
Development and Characterization of Excipient Enhanced Growth (EEG) Surfactant Powder Formulations for Treating Neonatal Respiratory Distress Syndrome.用于治疗新生儿呼吸窘迫综合征的辅料增强生长（EEG）表面活性剂粉末制剂的研发与特性研究
AAPS PharmSciTech. 2021 Apr 15;22(4):136. doi: 10.1208/s12249-021-02001-1.
3
Surfactant replacement therapy.表面活性剂替代疗法。
Thorax. 1996 Nov;51(11):1137-54. doi: 10.1136/thx.51.11.1137.
4
Early changes in lung function and response to surfactant replacement therapy.
Eur J Pediatr. 1994 Jul;153(7):495-500. doi: 10.1007/BF01957004.
5
Replacement of surfactant in hyaline membrane disease.透明膜病中表面活性剂的替代
Br Med J (Clin Res Ed). 1984 Oct 6;289(6449):855-7. doi: 10.1136/bmj.289.6449.855.
6
Effect of exogenous surfactant on total respiratory system compliance.外源性表面活性剂对总呼吸系统顺应性的影响。
Arch Dis Child. 1984 Apr;59(4):369-71. doi: 10.1136/adc.59.4.369.
7
Artificial surfactant in preterm rabbits with and without respiratory distress syndrome: difference of in vitro and in vivo activities.有无呼吸窘迫综合征的早产兔体内外人工表面活性剂活性的差异
Eur J Pediatr. 1985 Jul;144(2):195-9. doi: 10.1007/BF00451913.
8
Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.外源性表面活性剂治疗新生儿呼吸窘迫综合征及其在成人呼吸窘迫综合征中的潜在作用。
Drugs. 1989 Oct;38(4):591-611. doi: 10.2165/00003495-198938040-00006.
本文引用的文献
1
Critical assessment of jacket plethysmographs for use in young children.用于幼儿的套式体积描记器的批判性评估。
J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):267-73. doi: 10.1152/jappl.1982.52.1.267.
2
Sequential treatments of premature lambs with an artificial surfactant and natural surfactant.用人工表面活性剂和天然表面活性剂对早产羔羊进行序贯治疗。
J Clin Invest. 1981 Aug;68(2):491-6. doi: 10.1172/jci110280.
3
Artificial surfactant therapy in hyaline-membrane disease.透明膜病的人工表面活性剂治疗
Lancet. 1980 Jan 12;1(8159):55-9. doi: 10.1016/s0140-6736(80)90489-4.
4
A new method for measuring static compliance in infants and young children.
Clin Sci. 1972 Nov;43(5):689-94. doi: 10.1042/cs0430689.
5
Physical and physiological properties of dry lung surfactant.
Nature. 1978 Jan 12;271(5641):162-3. doi: 10.1038/271162a0.
Zotero 插件